Organigram Holdings Inc. Non-operating Income/Expense

Non-operating Income/Expense of OGI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Non-operating Income/Expense growth rates and interactive chart. Income or expense that is usually non-recurring and not tied to a company's operations. It is stated separately on the income statement to differentiate it from operating expenses.

Highlights and Quick Summary

  • Non-operating Income/Expense for the quarter ending February 28, 2023 was $2.49 Million (a 222.5% increase compared to previous quarter)
  • Year-over-year quarterly Non-operating Income/Expense decreased by -66.59%
  • Annual Non-operating Income/Expense for 2022 was $22.6 Million (a -173.78% decrease from previous year)
  • Annual Non-operating Income/Expense for 2021 was $-30.7 Million (a 3587.36% increase from previous year)
  • Annual Non-operating Income/Expense for 2020 was $-832 Thousand (a -90.3% decrease from previous year)
  • Twelve month Non-operating Income/Expense ending February 28, 2023 was $12.2 Million (a -9.57% decrease compared to previous quarter)
  • Twelve month trailing Non-operating Income/Expense decreased by -30.84% year-over-year
Trailing Non-operating Income/Expense for the last four month:
28 Feb '23 30 Nov '22 31 Aug '22 31 May '22
$12.2 Million $13.5 Million $22.6 Million $17.7 Million
Visit stockrow.com/OGI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Non-operating Income/Expense of Organigram Holdings Inc.

Most recent Non-operating Income/Expenseof OGI including historical data for past 10 years.

Interactive Chart of Non-operating Income/Expense of Organigram Holdings Inc.

Organigram Holdings Inc. Non-operating Income/Expense for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 $2.49 – – – –
2022 $0.77 $1.52 $7.44 $3.78 $22.63
2021 $9.89 $-3.44 $6.55 $-29.12 $-30.67
2020 $-4.65 $2.83 $-0.38 $-2.66 $-0.83
2019 $-0.62 $-0.77 $-0.85 $-3.93 $-8.57
2018 – – – $-3.01 $-6.77
2017 – – – – $1.08
2016 – – – – $-0.22

Business Profile of Organigram Holdings Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic
© stockrow.com